Cargando…

Treatment May Be Harmful: Mechanisms/Prediction/Prevention of Drug-Induced DNA Damage and Repair in Multiple Myeloma

Multiple myeloma (MM) is a malignancy characterized by accumulation of malignant plasma cells within the bone marrow (BM). MM is considered mostly without definitive treatment because of the inability of standard of care therapies to overcome drug-resistant relapse. Genotoxic agents are used in the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gourzones, Claire, Bret, Caroline, Moreaux, Jerome
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6759943/ https://www.ncbi.nlm.nih.gov/pubmed/31620167 http://dx.doi.org/10.3389/fgene.2019.00861

Ejemplares similares

A DNA repair pathway score predicts survival in human multiple myeloma: the potential for therapeutic strategy
por: Kassambara, Alboukadel, et al.
Publicado: (2014)

Antioxidant Defenses Confer Resistance to High Dose Melphalan in Multiple Myeloma Cells
por: Gourzones, Claire, et al.
Publicado: (2019)

Nucleotide excision DNA repair pathway as a therapeutic target in patients with high-risk diffuse large B cell lymphoma
por: Bret, Caroline, et al.
Publicado: (2013)

Kinome expression profiling to target new therapeutic avenues in multiple myeloma
por: de Boussac, Hugues, et al.
Publicado: (2020)

Understanding DNA Damage Response and DNA Repair in Multiple Myeloma
por: Petrilla, Cole, et al.
Publicado: (2023)

Drug Targeting of Genomic Instability in Multiple Myeloma
por: Beksac, Meral, et al.
Publicado: (2020)

Targeting the methyltransferase SETD8 impairs tumor cell survival and overcomes drug resistance independently of p53 status in multiple myeloma
por: Herviou, Laurie, et al.
Publicado: (2021)

RECQ1 helicase is involved in replication stress survival and drug resistance in multiple myeloma
por: Viziteu, E, et al.
Publicado: (2017)

DNA Repair Expression Profiling to Identify High-Risk Cytogenetically Normal Acute Myeloid Leukemia and Define New Therapeutic Targets
por: Gabellier, Ludovic, et al.
Publicado: (2020)

Radioresistance, DNA Damage and DNA Repair in Cells With Moderate Overexpression of RPA1
por: Velegzhaninov, Ilya O., et al.
Publicado: (2020)

The role of DNA damage and repair in decitabine-mediated apoptosis in multiple myeloma
por: Maes, Ken, et al.
Publicado: (2014)

Multi-omics tumor profiling technologies to develop precision medicine in multiple myeloma
por: Ovejero, Sara, et al.
Publicado: (2021)

Mutational spectrum of DNA damage and mismatch repair genes in prostate cancer
por: Bugoye, Fidelis Charles, et al.
Publicado: (2023)

RNA-Sequencing-Based Transcriptomic Score with Prognostic and Theranostic Values in Multiple Myeloma
por: Alaterre, Elina, et al.
Publicado: (2021)

The Clinical Significance of DNA Damage Repair Signatures in Clear Cell Renal Cell Carcinoma
por: Guo, Ergang, et al.
Publicado: (2021)

DNA Damage Repair-Related Genes Signature for Immune Infiltration and Outcome in Cervical Cancer
por: Wang, Xinghao, et al.
Publicado: (2022)

DNA Damage Repair and Current Therapeutic Approaches in Gastric Cancer: A Comprehensive Review
por: Wang, Menghui, et al.
Publicado: (2022)

Correlation of GDFT combined with rehabilitation therapy in DNA damage repair of esophageal cancer cells
por: Yan, Lihua, et al.
Publicado: (2023)

Drug metabolism and clearance system in tumor cells of patients with multiple myeloma
por: Hassen, Wafa, et al.
Publicado: (2014)

Somatic Genomic Mosaicism in Multiple Myeloma
por: Ye, Christine J., et al.
Publicado: (2020)

Identification and Validation of a Novel DNA Damage and DNA Repair Related Genes Based Signature for Colon Cancer Prognosis
por: Wang, Xue-quan, et al.
Publicado: (2021)

MicroRNAs: New Players in Multiple Myeloma
por: Pichiorri, Flavia, et al.
Publicado: (2011)

Animal Models of Multiple Myeloma Bone Disease
por: Mehdi, Syed Hassan, et al.
Publicado: (2021)

Unveiling DNA damage repair-based molecular subtypes, tumor microenvironment and pharmacogenomic landscape in gastric cancer
por: Kong, Weiqi, et al.
Publicado: (2023)

SNaPshot as a Valuable Option for the Identification of Mutations in Myeloma
por: Moreaux, Jerome
Publicado: (2014)

Germline Risk Contribution to Genomic Instability in Multiple Myeloma
por: Janz, Siegfried, et al.
Publicado: (2019)

Biomarker-driven drug repurposing on biologically similar cancers with DNA-repair deficiencies
por: Munj, Seeya Awadhut, et al.
Publicado: (2022)

Screening of DNA Damage Repair Genes Involved in the Prognosis of Triple-Negative Breast Cancer Patients Based on Bioinformatics
por: Wang, Nan, et al.
Publicado: (2021)

P844: CHARACTERIZATION OF MULTIPLE MYELOMA CELL LINES WITH ACQUIRED-RESISTANCE TO PROTEASOME INHIBITORS HIGHLIGHTS A LINK BETWEEN RESISTANCE AND METABOLIC DEREGULATION
por: De Boussac, H., et al.
Publicado: (2022)

A Five-Gene Signature Associated With DNA Damage Repair Molecular Subtype Predict Overall Survival for Hepatocellular Carcinoma
por: Huo, Junyu, et al.
Publicado: (2022)

Xeroderma Pigmentosum C (XPC) Mutations in Primary Fibroblasts Impair Base Excision Repair Pathway and Increase Oxidative DNA Damage
por: Fayyad, Nour, et al.
Publicado: (2020)

A DNA Damage Repair Gene Signature Associated With Immunotherapy Response and Clinical Prognosis in Clear Cell Renal Cell Carcinoma
por: Peng, Linjie, et al.
Publicado: (2022)

The Role of DNA Repair in Genomic Instability of Multiple Myeloma
por: Ali, Jana Yasser Hafez, et al.
Publicado: (2022)

Targeting the Interplay between HDACs and DNA Damage Repair for Myeloma Therapy
por: Gkotzamanidou, Maria, et al.
Publicado: (2021)

ANKLE1 as New Hotspot Mutation for Breast Cancer in Indian Population and Has a Role in DNA Damage and Repair in Mammalian Cells
por: Bakshi, Divya, et al.
Publicado: (2021)

m(7)G-Related DNA Damage Repair Genes are Potential Biomarkers for Predicting Prognosis and Immunotherapy Effectiveness in Colon Cancer Patients
por: Chen, Shuran, et al.
Publicado: (2022)

Gene expression-based risk score in diffuse large B-cell lymphoma
por: Bret, Caroline, et al.
Publicado: (2012)

Simultaneous Presentation of Waldenström's Macroglobulinemia and MYD88 Gene Mutation with Multiple Myeloma
por: Awada, Hassan, et al.
Publicado: (2019)

The Use of Murine Models for Studying Mechanistic Insights of Genomic Instability in Multiple Myeloma
por: Vlummens, Philip, et al.
Publicado: (2019)

Comprehensive analysis of prognosis of cuproptosis-related oxidative stress genes in multiple myeloma
por: Li, Tingting, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0ko5hbqklmqc559hdkabgji5c9